XERS
Xeris Biopharma Holdings, Inc.$6.08-0.04 (-0.65%)Prev Close$6.12·MCap$1.03B·P/E—·Vol688.4K·Yield—
▲
Buys (12M)
1
$109.5K
▼
Sells (12M)
24
$10.45M
◆
Net Activity
Net Seller
$10.34M
●
Active Insiders
11
last 12 mo
Over the past 12 months, insider activity at Xeris Biopharma Holdings, Inc. (XERS) has been dominated by selling, with 1 insider purchase totaling $109.5K and 24 insider sales totaling $10.45M. The most recent insider transaction was by Hecht Beth (officer: See Remarks), who sold $99.9K worth of shares on Apr 3, 2026. Xeris Biopharma Holdings, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.03B.
XERS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 3, 2026 | Hecht Beth | officer: See Remarks | Sell | 16,667 | $5.99 | $99.9K | 1,209,840 |
| Apr 1, 2026 | Brady James Aloysius | director | Sell | 10,834 | $5.54 | $60.0K | 89,166 |
| Feb 2, 2026 | Hecht Beth | officer: See Remarks | Sell | 16,667 | $7.45 | $124.1K | 1,243,174 |
| Jan 30, 2026 | Hecht Beth | See Remarks | Sell | 186,222 | $7.37 | $1.37M | 0 |
| Jan 30, 2026 | McCulloch Kevin | See Remarks | Sell | 126,062 | $7.36 | $927.8K | 0 |
| Jan 30, 2026 | Pieper Steven | See Remarks | Sell | 178,215 | $7.36 | $1.31M | 0 |
| Jan 30, 2026 | Shannon John Patrick Jr | See Remarks | Sell | 340,505 | $7.36 | $2.51M | 0 |
| Jan 8, 2026 | McCulloch Kevin | See Remarks | Sell | 15,000 | $8.00 | $120.0K | 0 |
| Jan 6, 2026 | Shannon John Patrick Jr | director, officer: See Remarks | Sell | 24,907 | $7.08 | $176.3K | 2,705,346 |
| Jan 5, 2026 | Hecht Beth | officer: See Remarks | Sell | 16,667 | $7.43 | $123.8K | 1,308,103 |
| Jan 5, 2026 | Shannon John Patrick Jr | See Remarks | Sell | 24,907 | $7.08 | $176.3K | 0 |
| Jan 2, 2026 | Hecht Beth | See Remarks | Sell | 16,667 | $7.43 | $123.8K | 0 |
| Dec 19, 2025 | JOHNSON JOHN | Director | Sell | 135,400 | $7.22 | $977.0K | 0 |
| Dec 12, 2025 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | Sell | 15,000 | $7.09 | $106.4K | 0 |
| Dec 1, 2025 | Hecht Beth | See Remarks | Sell | 16,667 | $7.01 | $116.8K | 0 |
| Nov 13, 2025 | Shannon John Patrick Jr | See Remarks | Sell | 23,242 | $7.46 | $173.4K | 0 |
| Nov 11, 2025 | Hecht Beth | See Remarks | Sell | 16,667 | $7.40 | $123.3K | 0 |
| Oct 2, 2025 | McCulloch Kevin | See Remarks | Sell | 733 | $8.31 | $6.1K | 0 |
| Sep 11, 2025 | PERSKY MARLA | Director | Sell | 15,500 | $7.72 | $119.6K | 0 |
| Aug 28, 2025 | SHERMAN JEFFREY W | Director | Sell | 42,232 | $7.92 | $334.5K | 0 |
| Aug 13, 2025 | JOHNSON JOHN | Director | Sell | 107,500 | $7.32 | $786.5K | 0 |
| Aug 12, 2025 | HALKUFF DAWN | Director | Sell | 42,500 | $7.28 | $309.2K | 0 |
| Aug 1, 2025 | McCulloch Kevin | See Remarks | Sell | 14,651 | $5.38 | $78.8K | 0 |
| Aug 1, 2025 | Shannon John Patrick Jr | See Remarks | Sell | 36,918 | $5.38 | $198.6K | 0 |
| Jun 13, 2025 | McCulloch Kevin | See Remarks | Buy | 25,000 | $4.38 | $109.5K | 0 |
| Apr 2, 2025 | McCulloch Kevin | See Remarks | Sell | 733 | $5.15 | $3.8K | 0 |
| Mar 20, 2025 | Hecht Beth | See Remarks | Sell | 40,000 | $5.43 | $217.2K | 0 |
| Aug 13, 2024 | Schmid John P. | Director | Buy | 4,515 | $2.25 | $10.1K | 25,200 |
| Aug 12, 2024 | Schmid John P. | Director | Buy | 4,285 | $2.37 | $10.1K | 20,685+26% |
| May 10, 2024 | Schmid John P. | Director | Buy | 5,400 | $1.91 | $10.3K | 16,400+49% |
| Mar 14, 2024 | Schmid John P. | Director | Buy | 4,500 | $2.16 | $9.7K | 11,000+69% |
| Nov 29, 2023 | SHERMAN JEFFREY W | Director | Buy | 5,400 | $1.87 | $10.1K | 5,400 |
| Nov 21, 2023 | HALKUFF DAWN | Director | Buy | 5,410 | $1.84 | $10.0K | 5,410 |
| Nov 21, 2023 | Pieper Steven | See Remarks | Buy | 28,000 | $1.95 | $54.6K | 1,176,912 |
| Nov 17, 2023 | Schmid John P. | Director | Buy | 6,500 | $1.51 | $9.8K | 6,500 |
| Nov 17, 2023 | Shannon John Patrick Jr | See Remarks | Buy | 30,769 | $1.64 | $50.4K | 1,408,575 |
| Nov 15, 2023 | PERSKY MARLA | Director | Buy | 6,370 | $1.58 | $10.1K | 6,370 |
| Aug 9, 2023 | Edick Paul R | See Remarks | Buy | 10,000 | $2.38 | $23.8K | 2,288,064 |
| Dec 14, 2022 | Edick Paul R | See Remarks | Buy | 20,000 | $1.45 | $29.0K | 1,528,064 |
| May 13, 2022 | Edick Paul R | See Remarks | Buy | 100,000 | $1.40 | $140.4K | 1,508,064 |
| Feb 24, 2022 | PRESTRELSKI STEVEN | Chief Scientific Officer | Sell | 11,228 | $2.42 | $27.2K | 569,780 |
| Nov 16, 2021 | Edick Paul R | See Remarks | Buy | 20,000 | $2.28 | $45.7K | 33,430+149% |
| Nov 12, 2021 | Edick Paul R | See Remarks | Buy | 200,000 | $2.08 | $415.8K | 808,064+33% |
| Nov 12, 2021 | Pieper Steven | See Remarks | Buy | 25,000 | $2.00 | $49.9K | 183,108 |
| Nov 12, 2021 | Shannon John Patrick Jr | See Remarks | Buy | 100,000 | $2.10 | $209.5K | 363,829+38% |
XERS Insider Buying Activity
The following table shows recent insider purchases of Xeris Biopharma Holdings, Inc. (XERS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | McCulloch Kevin | See Remarks | Buy | 25,000 | $4.38 | $109.5K | 0 |
| Aug 13, 2024 | Schmid John P. | Director | Buy | 4,515 | $2.25 | $10.1K | 25,200 |
| Aug 12, 2024 | Schmid John P. | Director | Buy | 4,285 | $2.37 | $10.1K | 20,685+26% |
| May 10, 2024 | Schmid John P. | Director | Buy | 5,400 | $1.91 | $10.3K | 16,400+49% |
| Mar 14, 2024 | Schmid John P. | Director | Buy | 4,500 | $2.16 | $9.7K | 11,000+69% |
| Nov 29, 2023 | SHERMAN JEFFREY W | Director | Buy | 5,400 | $1.87 | $10.1K | 5,400 |
| Nov 21, 2023 | HALKUFF DAWN | Director | Buy | 5,410 | $1.84 | $10.0K | 5,410 |
| Nov 21, 2023 | Pieper Steven | See Remarks | Buy | 28,000 | $1.95 | $54.6K | 1,176,912 |
| Nov 17, 2023 | Schmid John P. | Director | Buy | 6,500 | $1.51 | $9.8K | 6,500 |
| Nov 17, 2023 | Shannon John Patrick Jr | See Remarks | Buy | 30,769 | $1.64 | $50.4K | 1,408,575 |
| Nov 15, 2023 | PERSKY MARLA | Director | Buy | 6,370 | $1.58 | $10.1K | 6,370 |
| Aug 9, 2023 | Edick Paul R | See Remarks | Buy | 10,000 | $2.38 | $23.8K | 2,288,064 |
| Dec 14, 2022 | Edick Paul R | See Remarks | Buy | 20,000 | $1.45 | $29.0K | 1,528,064 |
| May 13, 2022 | Edick Paul R | See Remarks | Buy | 100,000 | $1.40 | $140.4K | 1,508,064 |
| Nov 16, 2021 | Edick Paul R | See Remarks | Buy | 20,000 | $2.28 | $45.7K | 33,430+149% |
| Nov 12, 2021 | Edick Paul R | See Remarks | Buy | 200,000 | $2.08 | $415.8K | 808,064+33% |
| Nov 12, 2021 | Pieper Steven | See Remarks | Buy | 25,000 | $2.00 | $49.9K | 183,108 |
| Nov 12, 2021 | Shannon John Patrick Jr | See Remarks | Buy | 100,000 | $2.10 | $209.5K | 363,829+38% |
XERS Insider Selling Activity
The following table shows recent insider sales of Xeris Biopharma Holdings, Inc. (XERS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 3, 2026 | Hecht Beth | officer: See Remarks | Sell | 16,667 | $5.99 | $99.9K | 1,209,840 |
| Apr 1, 2026 | Brady James Aloysius | director | Sell | 10,834 | $5.54 | $60.0K | 89,166 |
| Feb 2, 2026 | Hecht Beth | officer: See Remarks | Sell | 16,667 | $7.45 | $124.1K | 1,243,174 |
| Jan 30, 2026 | Hecht Beth | See Remarks | Sell | 186,222 | $7.37 | $1.37M | 0 |
| Jan 30, 2026 | McCulloch Kevin | See Remarks | Sell | 126,062 | $7.36 | $927.8K | 0 |
| Jan 30, 2026 | Pieper Steven | See Remarks | Sell | 178,215 | $7.36 | $1.31M | 0 |
| Jan 30, 2026 | Shannon John Patrick Jr | See Remarks | Sell | 340,505 | $7.36 | $2.51M | 0 |
| Jan 8, 2026 | McCulloch Kevin | See Remarks | Sell | 15,000 | $8.00 | $120.0K | 0 |
| Jan 6, 2026 | Shannon John Patrick Jr | director, officer: See Remarks | Sell | 24,907 | $7.08 | $176.3K | 2,705,346 |
| Jan 5, 2026 | Hecht Beth | officer: See Remarks | Sell | 16,667 | $7.43 | $123.8K | 1,308,103 |
| Jan 5, 2026 | Shannon John Patrick Jr | See Remarks | Sell | 24,907 | $7.08 | $176.3K | 0 |
| Jan 2, 2026 | Hecht Beth | See Remarks | Sell | 16,667 | $7.43 | $123.8K | 0 |
| Dec 19, 2025 | JOHNSON JOHN | Director | Sell | 135,400 | $7.22 | $977.0K | 0 |
| Dec 12, 2025 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | Sell | 15,000 | $7.09 | $106.4K | 0 |
| Dec 1, 2025 | Hecht Beth | See Remarks | Sell | 16,667 | $7.01 | $116.8K | 0 |
| Nov 13, 2025 | Shannon John Patrick Jr | See Remarks | Sell | 23,242 | $7.46 | $173.4K | 0 |
| Nov 11, 2025 | Hecht Beth | See Remarks | Sell | 16,667 | $7.40 | $123.3K | 0 |
| Oct 2, 2025 | McCulloch Kevin | See Remarks | Sell | 733 | $8.31 | $6.1K | 0 |
| Sep 11, 2025 | PERSKY MARLA | Director | Sell | 15,500 | $7.72 | $119.6K | 0 |
| Aug 28, 2025 | SHERMAN JEFFREY W | Director | Sell | 42,232 | $7.92 | $334.5K | 0 |
| Aug 13, 2025 | JOHNSON JOHN | Director | Sell | 107,500 | $7.32 | $786.5K | 0 |
| Aug 12, 2025 | HALKUFF DAWN | Director | Sell | 42,500 | $7.28 | $309.2K | 0 |
| Aug 1, 2025 | McCulloch Kevin | See Remarks | Sell | 14,651 | $5.38 | $78.8K | 0 |
| Aug 1, 2025 | Shannon John Patrick Jr | See Remarks | Sell | 36,918 | $5.38 | $198.6K | 0 |
| Apr 2, 2025 | McCulloch Kevin | See Remarks | Sell | 733 | $5.15 | $3.8K | 0 |
| Mar 20, 2025 | Hecht Beth | See Remarks | Sell | 40,000 | $5.43 | $217.2K | 0 |
| Feb 24, 2022 | PRESTRELSKI STEVEN | Chief Scientific Officer | Sell | 11,228 | $2.42 | $27.2K | 569,780 |
XERS Insiders
Similar Stocks to XERS
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B